Filters
reset allOther countries
Results: 1 to 10 of 10
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Multiple Endoctine Neoplasia Type 2 (RET) Molecular Genetics Laboratory London Health Sciences Centre Canada | 5 | 1 |
|
Otogenetics Hereditary Cancers Otogenetics United States | 36 | 39 |
|
Hereditary Thyroid Cancer - RET Gene Analysis GeneKor MSA Greece | 4 | 1 |
|
Multiple Endocrine Neoplasia Type FMTC , Sequencing Exons (10,11,13,14) RET Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Comprehensive Hereditary Cancer Panel Baylor Genetics United States | 132 | 61 |
|
Hereditary Endocrine Cancer Panel Baylor Genetics United States | 51 | 15 |
|
Hereditary Paraganglioma/Pheochromocytoma Panel Baylor Genetics United States | 21 | 9 |
|
GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Spain | 3 | 1 |
|
RET - Related Familial medullary thyroid carcinoma Exeter Molecular Genetics Laboratory United Kingdom | 1 | 1 |
|
Multiple Endorine Neoplasia Type 2 Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital New Zealand | 2 | 1 |
|
Results: 1 to 10 of 10
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.